<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7237358\results\search\country\results.xml">
  <result pre="used for treating malaria; Artemisia annua (sweet wormwood) native to" exact="China" post="and Cinchona officinalis (Cinchona tree) native to South America"/>
  <result pre="detoxifying decoction (LCDD) widely used in treating COVID-19 patients in" exact="China" post="was developed based on four formulae described in the"/>
  <result pre="of Cinchona tree bark was rediscovered by Spanish settlers in" exact="Peru" post="in the mid-17th century. In the following years, Cinchona"/>
  <result pre="investigation for other indications (www.ClinicalTrials.gov). A preliminary clinical study in" exact="France" post="recently showed promising results of chloroquine and hydroxychloroquine in"/>
  <result pre="Joint Prevention and Control Mechanism of the State Council of" exact="China" post="on April 17, the initial trial indicated that LCDD"/>
  <result pre="viral infection-induced cytokine storm. Unfortunately, the success of LCDD in" exact="China" post="cannot be easily transferred to other countries for several"/>
  <result pre="TCM infrastructure and the general cultural acceptance of TCM in" exact="China" post="are lacking outside China. Hence, there is no mechanism"/>
  <result pre="COVID-19 as an investigational therapy or complementary medicine in the" exact="United States" post="for example. Second, although the US Food and Drug"/>
  <result pre="to value science enough, despite its purported importance. In the" exact="United States," post="for example, the total federal budget for major science"/>
 </snippets>
</snippetsTree>
